sunshine holdings Archives - Page 7 of 7

July 10, 2020

Sunshine Healthcare Lanka (SHL), the healthcare arm of the diversified Sri Lankan conglomerate Sunshine Holdings (CSE: SUN), has appointed Mr. Shantha Bandara as the Chief Executive Officer of its pharmaceutical division. The appointment came into effect from July 01, 2020. Shantha, who was the Chief Operating Officer of Sunshine Pharmaceuticals, counts more than 23 years […]

June 8, 2020

June 08, 2020: Fitch Ratings has revised the National Long-Term Rating of Sunshine Holdings (CSE:SUN), to ‘A(lka)’ from ‘A-(lka)’ and has simultaneously affirmed its Outlook Stable. The rating revision of the diversified conglomerate, along with two other non-financial corporates, follows the recalibration of Fitch’s Sri Lankan National Rating scale to reflect changes in the relative […]

May 28, 2020

FY20 Highlights Consolidated revenue of Rs.20.8 billion, a decrease of 8.0% YoY Boosts stake in Watawala Tea Ceylon to 100% PAT amounted to Rs. 1.8 billion, up 60.0% YoY, due to strong healthcare sector results Healthcare revenue up 19.7% YoY to Rs. 11.2 billion Consumer Goods revenue contracted 7.0% YoY to Rs 5.4 billion Agri […]

February 18, 2020

Sunshine-Holdings-Group-Managing-Director-Vish-Govindasamy.jpg

Sunshine Holdings Group Managing Director, Vish Govindsamy

Sunshine Holdings appoints Shantha Bandara as CEO of its Pharma Division

Fitch revises Sunshine Holdings’ National Long-Term Rating to ‘A(lka)’ from ‘A-(lka)’

Sunshine Group ups its stake in Consumer business while delivering strong profits for FY20 amidst unprecedented challenges

Sunshine Holdings’ YTD 2019/20 profitability boosted by gain from divestment of tea plantations business